Bioextrax Investor Relations Material
Bioextrax AB develops and commercializes a bio-extraction platform technology delivering high purity active ingredients from non-traditional sources with lower cost than traditional extraction methods like CO2. Bioextrax has developed specific patented and protected technology platforms to produce active pharmaceutical ingredients (APIs) such as Omega 3, polyunsaturated fatty acids, astaxanthin and squalene. Bioextrax AB is haedquartered in Lund, Sweden.
Rubrik's 2024 IPO: What Investors Need To Know
Explore Rubrik's journey to a 2024 IPO, its innovative cybersecurity solutions, and strategic growth, highlighting its impact on the tech sector.
29 Feb 2024
Pricing Power Through Scarcity: A Case Study of Ferrari
Explore how Ferrari's scarcity and brand strength amplify its pricing power, crucial for a luxury company's success.
27 Feb 2024
Jacob Wallenberg: The Chairman of Investor AB
Get to know Jacob Wallenberg, one of the most influential businessmen in Europe and a part of the fifth generation of the Wallenberg family.
28 Feb 2024